Form 4: PROCEPT BioRobotics EVP Sells Shares

Alaleh Nouri, EVP, CLO, and Corporate Secretary of PROCEPT BioRobotics Corp, reported the sale of 3,243 shares of common stock.

Summary

• Alaleh Nouri, Executive Vice President, Chief Legal Officer, and Corporate Secretary of PROCEPT BioRobotics Corp (PRCT), reported the sale of common stock.
• A total of 3,243 shares were sold in two separate transactions on March 10, 2026.
• The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025.
• The first transaction involved 3,098 shares sold at a weighted average price of $25.6037, with individual sales ranging from $25.11 to $25.96.
• The second transaction involved 145 shares sold at a weighted average price of $26.7379, with individual sales ranging from $26.365 to $26.98.
• Following these reported transactions, Alaleh Nouri directly beneficially owns 111,021 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for an insider transaction executed under a pre-planned Rule 10b5-1 trading plan, which reduces the likelihood of it being based on immediate negative sentiment.

Industry Context

StockSavvy.ai notes that insider sales, especially those executed under a pre-arranged Rule 10b5-1 plan, are common and do not necessarily indicate a change in management's outlook on the company's future. Such plans are often set up to allow insiders to diversify their holdings or manage liquidity without concerns about trading on material non-public information.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership. However, as it was executed under a Rule 10b5-1 plan, it is generally perceived as a routine diversification or liquidity event rather than a signal of a lack of confidence in the company's prospects.

Key Dates

Keywords

PROCEPT BioRobotics, PRCT, Insider Trading, Form 4, Stock Sale, Alaleh Nouri, Rule 10b5-1